載入...
Dosage-dependent copy number gains in E2f1 and E2f3 drive hepatocellular carcinoma
Disruption of the retinoblastoma (RB) tumor suppressor pathway, either through genetic mutation of upstream regulatory components or mutation of RB1 itself, is believed to be a required event in cancer. However, genetic alterations in the RB-regulated E2F family of transcription factors are infreque...
Na minha lista:
| 發表在: | J Clin Invest |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Society for Clinical Investigation
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5330731/ https://ncbi.nlm.nih.gov/pubmed/28134624 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI87583 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|